ACR 2023 Podcast - Day3D
Rheumnow Podcast

ACR 2023 Podcast - Day3D

2023-11-15

Bimekizumab in Active AS_ 5 Year Study
INVIGORATE-1 Study_ IV Secukinumab for Treatment of Active axSpA
Overlap of Inflammatory and Degenerative Features in Radiographic axSpA
People with AxSpa Need More Sleep

Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free